Walden Biosciences

Walden Biosciences is a biotechnology company dedicated to developing first-class, targeted therapies for patients with kidney diseases. The company is developing groundbreaking drugs that directly target the kidneys and will achieve success through their comprehensive understanding of novel kidney-specific biological pathways and their team's proven track record in drug discovery. The goal is to transform the treatment paradigm of kidney diseases by reversing its progression and enabling patients to return to a normal life.